Showing 1 - 7 results of 7 for search 'R. Malla', query time: 0.04s Refine Results
  1. 1
    Erratum and Addendum: “A Standalone PV System with a Hybrid P&O MPPT Optimization Technique”

    Erratum and Addendum: “A Standalone PV System with a Hybrid P&O MPPT Optimization Technique” by S. Hota, M. K. Sahu, J. M. R. Malla

    Published 2020-10-01
    Get full text
    Article
  2. 2
    Maternal hyperhomocysteinemia and congenital heart defects: A prospective case control study in Indian population

    Maternal hyperhomocysteinemia and congenital heart defects: A prospective case control study in Indian population by Reyaz A. Malik, Mohd. R. Lone, Asif Ahmed, Kaisar A. Koul, Rahid R. Malla

    Published 2017-01-01
    Get full text
    Article
  3. 3
    Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy

    Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy by Kishore Kumar Jella, Tahseen H. Nasti, Zhentian Li, Sudarshan R. Malla, Zachary S. Buchwald, Mohammad K Khan

    Published 2018-09-01
    Get full text
    Article
  4. 4
    Studies on the Reactions of Biapenem with VIM Metallo β-Lactamases and the Serine β-Lactamase KPC-2

    Studies on the Reactions of Biapenem with VIM Metallo β-Lactamases and the Serine β-Lactamase KPC-2 by Anka Lucic, Tika R. Malla, Karina Calvopiña, Catherine L. Tooke, Jürgen Brem, Michael A. McDonough, James Spencer, Christopher J. Schofield

    Published 2022-03-01
    Get full text
    Article
  5. 5
    Ileal bile acid transporter inhibition in Cyp2c70 KO mice ameliorates cholestatic liver injury

    Ileal bile acid transporter inhibition in Cyp2c70 KO mice ameliorates cholestatic liver injury by Jennifer K. Truong, Ashley L. Bennett, Caroline Klindt, Ajay C. Donepudi, Sudarshan R. Malla, Kimberly J. Pachura, Alex Zaufel, Tarek Moustafa, Paul A. Dawson, Saul J. Karpen

    Published 2022-09-01
    Get full text
    Article
  6. 6
    P581: PHASE II STUDY OF LOWER-INTENSITY FRONTLINE THERAPY FOR NEWLY DIAGNOSED PATIENTS WITH AML WHO ARE UNFIT OR OTHERWISE NOT ELIGIBLE FOR FRONTLINE CLINICAL TRIALS

    P581: PHASE II STUDY OF LOWER-INTENSITY FRONTLINE THERAPY FOR NEWLY DIAGNOSED PATIENTS WITH AML WHO ARE UNFIT OR OTHERWISE NOT ELIGIBLE FOR FRONTLINE CLINICAL TRIALS by S. Venugopal, E. Jabbour, N. Pemmaraju, G. Montalban-Bravo, K. S. Chien, N. Daver, N. Jain, J. Burger, Y. Alvarado, A. Maiti, C. D. DiNardo, G. Borthakur, R. Malla, G. Garcia-Manero, F. Ravandi, H. Kantarjian, T. Kadia

    Published 2022-06-01
    Get full text
    Article
  7. 7
    Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19

    Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19 by Martin A. Redhead, C. David Owen, Lennart Brewitz, Amelia H. Collette, Petra Lukacik, Claire Strain-Damerell, Sean W. Robinson, Patrick M. Collins, Philipp Schäfer, Mark Swindells, Chris J. Radoux, Iva Navratilova Hopkins, Daren Fearon, Alice Douangamath, Frank von Delft, Tika R. Malla, Laura Vangeel, Thomas Vercruysse, Jan Thibaut, Pieter Leyssen, Tu-Trinh Nguyen, Mitchell Hull, Anthony Tumber, David J. Hallett, Christopher J. Schofield, David I. Stuart, Andrew L. Hopkins, Martin A. Walsh

    Published 2021-06-01
    Get full text
    Article

Search Tools: